IDNA vs. FTEC
Compare and contrast key facts about iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) and Fidelity MSCI Information Technology Index ETF (FTEC).
IDNA and FTEC are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. IDNA is a passively managed fund by iShares that tracks the performance of the NYSE FactSet Global Genomics and Immuno Biopharma Index. It was launched on Jun 11, 2019. FTEC is a passively managed fund by Fidelity that tracks the performance of the MSCI USA IMI Information Technology Index. It was launched on Oct 21, 2013. Both IDNA and FTEC are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: IDNA or FTEC.
Key characteristics
IDNA | FTEC | |
---|---|---|
YTD Return | 5.08% | 10.37% |
1Y Return | 2.13% | 34.27% |
3Y Return (Ann) | -18.61% | 15.20% |
Sharpe Ratio | 0.05 | 2.01 |
Daily Std Dev | 25.10% | 18.38% |
Max Drawdown | -68.26% | -34.95% |
Current Drawdown | -55.49% | -0.72% |
Correlation
The correlation between IDNA and FTEC is 0.59, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
IDNA vs. FTEC - Performance Comparison
In the year-to-date period, IDNA achieves a 5.08% return, which is significantly lower than FTEC's 10.37% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
IDNA vs. FTEC - Expense Ratio Comparison
IDNA has a 0.47% expense ratio, which is higher than FTEC's 0.08% expense ratio.
Risk-Adjusted Performance
IDNA vs. FTEC - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) and Fidelity MSCI Information Technology Index ETF (FTEC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
IDNA vs. FTEC - Dividend Comparison
IDNA's dividend yield for the trailing twelve months is around 0.99%, more than FTEC's 0.70% yield.
TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund | 0.99% | 1.04% | 0.54% | 0.70% | 0.26% | 0.80% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Fidelity MSCI Information Technology Index ETF | 0.70% | 0.77% | 0.93% | 0.63% | 0.83% | 1.03% | 1.20% | 0.96% | 1.25% | 1.27% | 1.09% | 0.18% |
Drawdowns
IDNA vs. FTEC - Drawdown Comparison
The maximum IDNA drawdown since its inception was -68.26%, which is greater than FTEC's maximum drawdown of -34.95%. Use the drawdown chart below to compare losses from any high point for IDNA and FTEC. For additional features, visit the drawdowns tool.
Volatility
IDNA vs. FTEC - Volatility Comparison
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) and Fidelity MSCI Information Technology Index ETF (FTEC) have volatilities of 6.54% and 6.24%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.